Insights: News
As a diagnostics platform company that provides serious or complex laboratory testing, Mayo Clinic Laboratories is constantly working to advance patient care and broaden access to specialized testing. Learn about the latest news from Mayo Clinic Laboratories here, including new test launches, collaborations, operational updates, and more.
Most recent posts
Updated Sunday, Feb. 22 at 12:30 pm A significant nor'easter named Hernando is forecasted to impact the Northeastern United States beginning Sunday, Feb. 22, and[...]
Hurricane Idalia is expected to impact Florida on Wednesday, Aug. 30. We are monitoring and tracking the situation with our logistics partners to minimize challenges.
Hurricane Hilary will be impacting the West Coast this weekend and into early next week. We are monitoring and tracking the situation with our logistics partners to minimize challenges. Clients will be contacted directly by the couriers if a route is modified or canceled due to the storm. Additionally, we are identifying and activating alternate solutions to help deliver client specimens to Mayo Clinic Laboratories.
Due to the Labor Day holiday (recognized on Monday, September 4th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen viability and avoid turnaround time delays, follow the guidelines below.
Mayo Clinic Laboratories’ MayoComplete Melanoma Panel is a comprehensive test that better informs the prognosis and treatment of melanoma. It can be applied to unusual tumors that haven’t yet been identified as melanoma as well as melanomas with complex molecular structures.
At Mayo Clinic, quality is not an act, it’s a habit. This commitment extends into BioPharma Diagnostics, where a team of four quality assurance assistants and three lab processing assistants has recently come together as the BioPharma Accessioning Pod. Their focus includes accommodating the unique requirements of BioPharma clinical trials and research samples during accessioning and sharing data and findings with the BioPharma Diagnostics team.
Mayo Clinic Laboratories has developed a new colorectal cancer test, the MayoComplete Colorectal Cancer Panel (Mayo ID: MCCRC), in response to the latest recommendations for testing and treatment from the American Society of Clinical Oncology.
The MayoComplete Gastrointestinal Stromal Tumor (GIST) Panel, Next-Generation Sequencing, Tumor evaluates for somatic mutations in solid tumor samples and determines microsatellite instability to confirm a diagnosis of GIST.
The MayoACCESS test ordering application is now available and all technical issues have been resolved. However, if you still encounter issues when logging in to MayoACCESS, clear your browser cache and reboot your computer. Complete the following steps depending on your browser type:
In June 2023, Mayo Clinic Laboratories announced 28 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Due to the upcoming Independence Day holiday on Tuesday, July 4, Mayo Clinic Laboratories' sample pickup and delivery schedules will be altered. To ensure sample viability and minimize test turnaround time delays, we have implemented several adjustments and guidelines.
Mayo Clinic Laboratories’ new MayoComplete Lung Cancer Panel (Mayo ID: MCLNG) provides more information than single-gene assays and faster results than a comprehensive solid tumor panel that covers hundreds of genes.
A team of researchers has confirmed that neutralizing monoclonal antibody (nMAb) therapies are associated with reduced risk of adverse outcomes of COVID-19 in high-risk populations. The cohort study, published in JAMA, included more than 167,000 nonhospitalized patients from health care systems based in California, Texas, and Utah, and at Mayo Clinic in Rochester, Minnesota.